Ranbaxy Laboratories Limited on Friday raised its equity stake to 50 per cent in Nihon Pharmaceutical Industry Co Ltd (NPI), a joint-venture between the company and Nippon Chemiphar Co Ltd (NC), Japan from the present 10 per cent. With this enhancement, NPI will become a 50:50 JV between the two companies, a statement by Ranbaxy said. An agreement in this regard has been signed on Friday, it added.

Hindustan Times (http://www.hindustantimes.com/news/181_1543183,00020009.htm)